Recent advances in fluorescence imaging-guided photothermal therapy and photodynamic therapy for cancer: From near-infrared-I to near-infrared-II

被引:64
作者
Luo, Hangqi [1 ]
Gao, Shuai [2 ,3 ]
机构
[1] Yale Sch Med, Yale Cardiovasc Res Ctr, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06511 USA
[2] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurosurg, Harvey Cushing Neurooncol Labs, Boston, MA 02115 USA
[3] MIT, Dept Chem, Cambridge, MA 02139 USA
关键词
Photothermal therapy; Photodynamic therapy; Near-infrared-I; Near-infrared-II; Fluorescence imaging; Cancer therapy; MALIGNANT BRAIN-TUMORS; INDOCYANINE-GREEN; ORGANIC NANOPARTICLES; RATIONAL DESIGN; DENDRITIC CELLS; RECENT PROGRESS; T-CELLS; PHOTOSENSITIZERS; PORPHYRIN; DYE;
D O I
10.1016/j.jconrel.2023.08.056
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Phototherapy (including photothermal therapy, PTT; and photodynamic therapy, PDT) has been widely used for cancer treatment, but conventional PTT/PDT show limited therapeutic effects due to the lack of disease recognition ability. The integration of fluorescence imaging with PTT/PDT can reveal tumor locations in a realtime manner, holding great potential in early diagnosis and precision treatment of cancers. However, the traditional fluorescence imaging in the visible and near-infrared-I regions (VIS/NIR-I, 400-900 nm) might be interfered by the scattering and autofluorescence from tissues, leading to a low imaging resolution and high false positive rate. The deeper near-infrared-II (NIR-II, 1000-1700 nm) fluorescence imaging can address these interferences. Combining NIR-II fluorescence imaging with PTT/PDT can significantly improve the accuracy of tumor theranostics and minimize damages to normal tissues. This review summarized recent advances in tumor PTT/PDT and NIR-II fluorophores, especially discussed achievements, challenges and prospects around NIR-II fluorescence imaging-guided PTT/PDT for cancers.
引用
收藏
页码:425 / 445
页数:21
相关论文
共 249 条
[1]   Recent Progress in Cancer Thermal Therapy Using Gold Nanoparticles [J].
Abadeer, Nardine S. ;
Murphy, Catherine J. .
JOURNAL OF PHYSICAL CHEMISTRY C, 2016, 120 (09) :4691-4716
[2]  
Ackroyd R, 2001, PHOTOCHEM PHOTOBIOL, V74, P656, DOI 10.1562/0031-8655(2001)074<0656:THOPAP>2.0.CO
[3]  
2
[4]   A Photosensitized Singlet Oxygen (1O2) Toolbox for Bio-Organic Applications: Tailoring 1O2 Generation for DNA and Protein Labelling, Targeting and Biosensing [J].
Aerssens, Dorien ;
Cadoni, Enrico ;
Tack, Laure ;
Madder, Annemieke .
MOLECULES, 2022, 27 (03)
[5]   Photodynamic Therapy of Cancer: An Update [J].
Agostinis, Patrizia ;
Berg, Kristian ;
Cengel, Keith A. ;
Foster, Thomas H. ;
Girotti, Albert W. ;
Gollnick, Sandra O. ;
Hahn, Stephen M. ;
Hamblin, Michael R. ;
Juzeniene, Asta ;
Kessel, David ;
Korbelik, Mladen ;
Moan, Johan ;
Mroz, Pawel ;
Nowis, Dominika ;
Piette, Jacques ;
Wilson, Brian C. ;
Golab, Jakub .
CA-A CANCER JOURNAL FOR CLINICIANS, 2011, 61 (04) :250-281
[6]   Single-Molecular Near-Infrared-II Theranostic Systems: Ultrastable Aggregation-Induced Emission Nanoparticles for Long-Term Tracing and Efficient Photothermal Therapy [J].
Alifu, Nuernisha ;
Zebibula, Abudureheman ;
Qi, Ji ;
Zhang, Hequn ;
Sun, Chaowei ;
Yu, Xiaoming ;
Xue, Dingwei ;
Lam, Jacky W. Y. ;
Li, Gonghui ;
Qian, Jun ;
Tang, Ben Zhong .
ACS NANO, 2018, 12 (11) :11282-11293
[7]   Oncologic photodynamic therapy photosensitizers: A clinical review [J].
Allison, Ron R. ;
Sibata, Claudio H. .
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2010, 7 (02) :61-75
[8]   Progress in Clinical Trials of Photodynamic Therapy for Solid Tumors and the Role of Nanomedicine [J].
Alsaab, Hashem O. ;
Alghamdi, Maha S. ;
Alotaibi, Albatool S. ;
Alzhrani, Rami ;
Alwuthaynani, Fatimah ;
Althobaiti, Yusuf S. ;
Almalki, Atiah H. ;
Sau, Samaresh ;
Iyer, Arun K. .
CANCERS, 2020, 12 (10) :1-26
[9]  
Antaris AL, 2016, NAT MATER, V15, P235, DOI [10.1038/NMAT4476, 10.1038/nmat4476]
[10]   Boron dipyrromethene (BODIPY)-based photosensitizers for photodynamic therapy [J].
Awuah, Samuel G. ;
You, Youngjae .
RSC ADVANCES, 2012, 2 (30) :11169-11183